ACR Clinical Research Conference

描述(由申请人提供)：在过去的六年中，美国风湿病学会(ACR)通过其年度临床研究会议促进了临床研究，并为风湿病研究人员和临床医生之间的尖端科学信息交流创造了环境，这是ACR年会之前在会议地点举行的科学研讨会。这次年会的美国和国际关节炎健康专业人员的出席人数持续增加，目前已吸引了1万多名与会者。它是为交流关于研究、教育、病人护理和社会经济问题的想法提供论坛的主要机制。它也是传播与风湿病相关的尖端临床研究成果的主要形式。为了强调风湿病和肌肉骨骼患者研究的基础上的临床研究方法论，ACR于2004年开始在年会中建立强调临床研究的具体规划。拟议的五个会议中的第一个将与2010年在佐治亚州亚特兰大举行的ACR年度科学会议一起举行，其主题将是质量改进和证据实施研究。这将是一次最先进的会议，分为两个会议，第一个会议将强调质量改进的要点，第二个会议将集中于肌肉骨骼药物的应用。会议由肯尼斯·萨格博士和研究委员会(伊丽莎白·卡尔森博士)组织。萨格博士是阿拉巴马大学的医学和流行病学教授。他是一位风湿学家和国际知名的结果研究人员，在肌肉骨骼疾病和药物流行病学方面拥有专业知识，也是骨健康的临床重点。萨格博士在质量研究领域拥有丰富的专业知识，曾在制定关节炎和骨质疏松症指南和质量指标的国家委员会任职。已为随后的四次会议选择了主题：2011年将重点放在风湿病学的比较有效性研究；风湿性疾病结果的测量方法；结果研究的解释；药物安全性和有效性、成本效益以及试验设计的创新。已经选定了2012-2014年的暂定主题清单，(1)定义早期风湿病，病前状态(2)以患者为中心的结果和以医生为中心的结果(3)打破疼痛周期和(4)风湿病中的肺部疾病。

DESCRIPTION (provided by applicant): For the last six years the American College of Rheumatology (ACR) has facilitated clinical research and cultivated an environment for the exchange of cutting edge scientific information between investigators in rheumatic diseases and clinicians through its annual Clinical Research Conference, a scientific symposium that occurs immediately prior to the ACR Annual Meeting at the site of the meeting. The Annual Meeting, which has continued to grow in attendance of both US and international arthritis health professionals, now attracts more than 10,000 attendees. It is the principal mechanism for providing a forum for the exchange of ideas about research, education, patient care and socioeconomic issues. It is also the primary format for disseminating cutting edge clinical research findings relevant to rheumatic disorders. In order to emphasize the methodology of clinical research that underlies rheumatic and musculoskeletal patient oriented research, in 2004 the ACR began to build specific programming emphasizing clinical research into the Annual Meeting. The topic for the first of the five proposed conferences, to be held in conjunction with the 2010 ACR Annual Scientific Meeting in Atlanta, Georgia, will be Quality Improvement and Evidence Implementation Research. This will be a state-of-the-art conference divided into two sessions, session one will highlight the essentials of quality improvement and session two will be focused around applications to musculoskeletal medicine. The meeting has been organized by Dr. Kenneth Saag and the Committee on Research (Dr. Elizabeth Karlson). Dr. Saag is Professor of Medicine and Epidemiology at the University of Alabama. He is a rheumatologist and internationally known outcomes researcher with expertise in musculoskeletal disease and pharmacoepidemiology, and a clinical focus in bone health. Dr. Saag has significant expertise in the area of quality research and has served on national committees to develop both arthritis and osteoporosis guidelines and quality indicators. Topics have been chosen for the four subsequent conferences: 2011 will focus comparative effectiveness research in rheumatology; methodologies to measure outcomes in rheumatic diseases; interpretation of outcomes research; drug safety and effectiveness, cost effectiveness, and innovations in trial design. A list of tentative topics has been chosen for 2012-2014, (1) defining early rheumatic disease, the pre-disease state (2) patient centered outcomes and physician centered outcomes (3) breaking the pain cycle and (4) lung disease in rheumatology.